Cyclo Therapeutics
CYTH39
$0.64arrow_drop_down0.15%-$0.00
Penny Stock
CYTH39
$0.64
arrow_drop_down0.15%Performance History
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Cyclo Therapeutics (CYTH)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Mr. N. Scott Fine
- Headquarters
- Gainesville
- Employees
- 9
- Exchange
- NASDAQ
Keep an eye on Cyclo Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.